Bluebird bio Inc has teamed up with the Edinburgh, UK-based TC BioPharm Ltd to create new immunotherapies for cancer based on gamma delta T cells, a small subset of T cells involved in the initiation and propagation of immune responses. ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
